Trial Profile
A Phase II Study of PD-0332991 in Adult Patients With Advanced Hepatocellular Carcinoma
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 22 Dec 2023
Price :
$35
*
At a glance
- Drugs Palbociclib (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- 28 Nov 2023 Planned End Date changed from 1 Dec 2023 to 31 Dec 2024.
- 13 Dec 2022 Planned End Date changed from 1 Dec 2021 to 1 Dec 2023.
- 21 Sep 2021 Planned End Date changed from 1 Aug 2021 to 1 Dec 2021.